Boston Scientific CEO Mike Mahoney on Wednesday said the Farapulse pulsed field ablation system (PFA) drove increased procedure volumes in the company’s electrophysiology business, where sales climbed ...
The sedate uptake of pulsed field ablation (PFA) in Europe failed to presage the enthusiasm that drove the technology’s extraordinarily rapid adoption in the U.S. in 2024. Used to treat atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results